BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34076987)

  • 21. Hepatocellular carcinoma progression is protected by miRNA-34c-5p by regulating FAM83A.
    Yu WS; Wang ZG; Guo RP; Lin ZQ; Ye ZW; Lu CL
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6046-6054. PubMed ID: 32572919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
    Hu J; Ruan J; Liu X; Xiao C; Xiong J
    Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
    Yin J; Liu Q; Chen C; Liu W
    J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
    Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
    Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in cell stemness and gemcitabine resistance of hepatocellular carcinoma.
    Tang B; Xie L; Tang X; Tian J; Xiao S
    Mol Cell Probes; 2023 Oct; 71():101924. PubMed ID: 37536457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
    Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
    Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
    Cui ZH; Shen SQ; Chen ZB; Hu C
    World J Gastroenterol; 2014 May; 20(18):5493-504. PubMed ID: 24833879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
    Li JZ; Li J; Liu BZ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
    Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
    Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
    Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
    J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA TATDN1 induces the progression of hepatocellular carcinoma via targeting miRNA-6089.
    Shen C; Xu Y; Lu TF; Zhang JJ; Qian YB; Xu N
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6459-6466. PubMed ID: 31378885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.